A compound will not have to be stated to be a controlled material because of the DEA being treated like a Schedule I compound for prison prosecution. A managed compound analogue (for instance, a "designer drug") is actually a compound which happens to be structurally or pharmacologically similar to a Schedule I or Timetable II substance, specifical